Breithorn Capital Management’s Accretive Health AH Stock Holding History

Breithorn Capital Management’s Portfolio AH Stock Details AH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-289,076	Closed	-$2.24M	–	52
2014 Q3	$2.24M	Buy	289,076 +83,245	+40%	+$646K	1.46%	32
2014 Q2	$1.6M	Buy	+205,831	New	+$1.6M	1%	30

Other funds holding AH

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

RMC

Regis Management Company Menlo Park, California $331M AUM 14.13% 1-Year Est. Return

Breithorn Capital Management's AH Position: Q4 2014 in Review

Breithorn Capital Management sold out of Accretive Health (AH) in Q4 2014, closing a stake of 289,076 shares — an estimated $2.24M sold.

Breithorn Capital Management first reported a position in AH in Q2 2014 and held it in 2 quarters. The position peaked at $2.24M in Q3 2014. 3 funds tracked by Wall St. Rank hold AH as of Q4 2014.

Breithorn Capital Management reported no remaining Accretive Health position as of Q4 2014 after selling out during the quarter.
Breithorn Capital Management sold 289,076 Accretive Health shares in Q4 2014, an estimated $2.24M.
Breithorn Capital Management first reported a position in Accretive Health in Q2 2014 and held it in 2 quarters.
Breithorn Capital Management's Accretive Health position peaked at $2.24M in Q3 2014.
3 funds tracked by Wall St. Rank held Accretive Health as of Q4 2014.

Based on Breithorn Capital Management's 13F filing for Q4 2014, filed 13 Feb 2015.